1 Study Coverage 1.1 Glycopeptide Antibiotics Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Glycopeptide Antibiotics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Glycopeptide Antibiotics Market Size for the Year 2017-2028 1.2.2 Global Glycopeptide Antibiotics Market Size for the Year 2017-2028 1.3 Glycopeptide Antibiotics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Glycopeptide Antibiotics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Glycopeptide Antibiotics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Glycopeptide Antibiotics Market Dynamics 1.4.1 Glycopeptide Antibiotics Industry Trends 1.4.2 Glycopeptide Antibiotics Market Drivers 1.4.3 Glycopeptide Antibiotics Market Challenges 1.4.4 Glycopeptide Antibiotics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Glycopeptide Antibiotics by Type 2.1 Glycopeptide Antibiotics Market Segment by Type 2.1.1 Vancomycin 2.1.2 Teicoplanin 2.1.3 Bleomycin 2.2 Global Glycopeptide Antibiotics Market Size by Type (2017, 2022 & 2028) 2.3 Global Glycopeptide Antibiotics Market Size by Type (2017-2028) 2.4 United States Glycopeptide Antibiotics Market Size by Type (2017, 2022 & 2028) 2.5 United States Glycopeptide Antibiotics Market Size by Type (2017-2028) 3 Glycopeptide Antibiotics by Application 3.1 Glycopeptide Antibiotics Market Segment by Application 3.1.1 Enterococcus Treatment 3.1.2 Staphylococcus Aureus Treatment 3.2 Global Glycopeptide Antibiotics Market Size by Application (2017, 2022 & 2028) 3.3 Global Glycopeptide Antibiotics Market Size by Application (2017-2028) 3.4 United States Glycopeptide Antibiotics Market Size by Application (2017, 2022 & 2028) 3.5 United States Glycopeptide Antibiotics Market Size by Application (2017-2028) 4 Global Glycopeptide Antibiotics Competitor Landscape by Company 4.1 Global Glycopeptide Antibiotics Market Size by Company 4.1.1 Top Global Glycopeptide Antibiotics Companies Ranked by Revenue (2021) 4.1.2 Global Glycopeptide Antibiotics Revenue by Player (2017-2022) 4.2 Global Glycopeptide Antibiotics Concentration Ratio (CR) 4.2.1 Glycopeptide Antibiotics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Glycopeptide Antibiotics in 2021 4.2.3 Global Glycopeptide Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Glycopeptide Antibiotics Headquarters, Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Glycopeptide Antibiotics Headquarters and Area Served 4.3.2 Global Glycopeptide Antibiotics Companies Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Glycopeptide Antibiotics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Glycopeptide Antibiotics Market Size by Company 4.5.1 Top Glycopeptide Antibiotics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Glycopeptide Antibiotics Revenue by Players (2020, 2021 & 2022) 5 Global Glycopeptide Antibiotics Market Size by Region 5.1 Global Glycopeptide Antibiotics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Glycopeptide Antibiotics Market Size by Region (2017-2028) 5.2.1 Global Glycopeptide Antibiotics Market Size by Region: 2017-2022 5.2.2 Global Glycopeptide Antibiotics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Glycopeptide Antibiotics Market Size YoY Growth 2017-2028 6.1.2 North America Glycopeptide Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Glycopeptide Antibiotics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Glycopeptide Antibiotics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Glycopeptide Antibiotics Market Size YoY Growth 2017-2028 6.3.2 Europe Glycopeptide Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Glycopeptide Antibiotics Market Size YoY Growth 2017-2028 6.4.2 Latin America Glycopeptide Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Glycopeptide Antibiotics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Glycopeptide Antibiotics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 ANI Pharmaceuticals 7.1.1 ANI Pharmaceuticals Company Details 7.1.2 ANI Pharmaceuticals Business Overview 7.1.3 ANI Pharmaceuticals Glycopeptide Antibiotics Introduction 7.1.4 ANI Pharmaceuticals Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.1.5 ANI Pharmaceuticals Recent Development 7.2 Hikma Pharmaceuticals plc 7.2.1 Hikma Pharmaceuticals plc Company Details 7.2.2 Hikma Pharmaceuticals plc Business Overview 7.2.3 Hikma Pharmaceuticals plc Glycopeptide Antibiotics Introduction 7.2.4 Hikma Pharmaceuticals plc Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.2.5 Hikma Pharmaceuticals plc Recent Development 7.3 Aurobindo Pharma 7.3.1 Aurobindo Pharma Company Details 7.3.2 Aurobindo Pharma Business Overview 7.3.3 Aurobindo Pharma Glycopeptide Antibiotics Introduction 7.3.4 Aurobindo Pharma Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.3.5 Aurobindo Pharma Recent Development 7.4 Allergan 7.4.1 Allergan Company Details 7.4.2 Allergan Business Overview 7.4.3 Allergan Glycopeptide Antibiotics Introduction 7.4.4 Allergan Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.4.5 Allergan Recent Development 7.5 Theravance Biopharma 7.5.1 Theravance Biopharma Company Details 7.5.2 Theravance Biopharma Business Overview 7.5.3 Theravance Biopharma Glycopeptide Antibiotics Introduction 7.5.4 Theravance Biopharma Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.5.5 Theravance Biopharma Recent Development 7.6 Shenwei Pharmaceutical 7.6.1 Shenwei Pharmaceutical Company Details 7.6.2 Shenwei Pharmaceutical Business Overview 7.6.3 Shenwei Pharmaceutical Glycopeptide Antibiotics Introduction 7.6.4 Shenwei Pharmaceutical Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.6.5 Shenwei Pharmaceutical Recent Development 7.7 Zhejiang Hisun Pharmaceutical Co., Ltd. 7.7.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Details 7.7.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview 7.7.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Introduction 7.7.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.7.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development 7.8 Lytix Biopharma 7.8.1 Lytix Biopharma Company Details 7.8.2 Lytix Biopharma Business Overview 7.8.3 Lytix Biopharma Glycopeptide Antibiotics Introduction 7.8.4 Lytix Biopharma Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.8.5 Lytix Biopharma Recent Development 7.9 Alvogen 7.9.1 Alvogen Company Details 7.9.2 Alvogen Business Overview 7.9.3 Alvogen Glycopeptide Antibiotics Introduction 7.9.4 Alvogen Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.9.5 Alvogen Recent Development 7.10 Eli Lilly and Company 7.10.1 Eli Lilly and Company Company Details 7.10.2 Eli Lilly and Company Business Overview 7.10.3 Eli Lilly and Company Glycopeptide Antibiotics Introduction 7.10.4 Eli Lilly and Company Revenue in Glycopeptide Antibiotics Business (2017-2022) 7.10.5 Eli Lilly and Company Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Glycopeptide Antibiotics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Glycopeptide Antibiotics Market Trends Table 3. Glycopeptide Antibiotics Market Drivers Table 4. Glycopeptide Antibiotics Market Challenges Table 5. Glycopeptide Antibiotics Market Restraints Table 6. Global Glycopeptide Antibiotics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Glycopeptide Antibiotics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Glycopeptide Antibiotics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Glycopeptide Antibiotics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Glycopeptide Antibiotics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Glycopeptide Antibiotics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Glycopeptide Antibiotics Revenue Share by Player, 2017-2022 Table 13. Global Glycopeptide Antibiotics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Glycopeptide Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopeptide Antibiotics as of 2021) Table 15. Top Players of Glycopeptide Antibiotics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Glycopeptide Antibiotics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Glycopeptide Antibiotics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Glycopeptide Antibiotics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Glycopeptide Antibiotics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Glycopeptide Antibiotics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Glycopeptide Antibiotics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Glycopeptide Antibiotics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Glycopeptide Antibiotics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Glycopeptide Antibiotics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Glycopeptide Antibiotics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Glycopeptide Antibiotics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Glycopeptide Antibiotics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. ANI Pharmaceuticals Company Details Table 31. ANI Pharmaceuticals Business Overview Table 32. ANI Pharmaceuticals Glycopeptide Antibiotics Product Table 33. ANI Pharmaceuticals Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 34. ANI Pharmaceuticals Recent Development Table 35. Hikma Pharmaceuticals plc Company Details Table 36. Hikma Pharmaceuticals plc Business Overview Table 37. Hikma Pharmaceuticals plc Glycopeptide Antibiotics Product Table 38. Hikma Pharmaceuticals plc Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 39. Hikma Pharmaceuticals plc Recent Development Table 40. Aurobindo Pharma Company Details Table 41. Aurobindo Pharma Business Overview Table 42. Aurobindo Pharma Glycopeptide Antibiotics Product Table 43. Aurobindo Pharma Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 44. Aurobindo Pharma Recent Development Table 45. Allergan Company Details Table 46. Allergan Business Overview Table 47. Allergan Glycopeptide Antibiotics Product Table 48. Allergan Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 49. Allergan Recent Development Table 50. Theravance Biopharma Company Details Table 51. Theravance Biopharma Business Overview Table 52. Theravance Biopharma Glycopeptide Antibiotics Product Table 53. Theravance Biopharma Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 54. Theravance Biopharma Recent Development Table 55. Shenwei Pharmaceutical Company Details Table 56. Shenwei Pharmaceutical Business Overview Table 57. Shenwei Pharmaceutical Glycopeptide Antibiotics Product Table 58. Shenwei Pharmaceutical Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 59. Shenwei Pharmaceutical Recent Development Table 60. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Details Table 61. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 62. Zhejiang Hisun Pharmaceutical Co., Ltd. Glycopeptide Antibiotics Product Table 63. Zhejiang Hisun Pharmaceutical Co., Ltd. Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 64. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 65. Lytix Biopharma Company Details Table 66. Lytix Biopharma Business Overview Table 67. Lytix Biopharma Glycopeptide Antibiotics Product Table 68. Lytix Biopharma Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 69. Lytix Biopharma Recent Development Table 70. Alvogen Company Details Table 71. Alvogen Business Overview Table 72. Alvogen Glycopeptide Antibiotics Product Table 73. Alvogen Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 74. Alvogen Recent Development Table 75. Eli Lilly and Company Company Details Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Glycopeptide Antibiotics Product Table 78. Eli Lilly and Company Revenue in Glycopeptide Antibiotics Business (2017-2022) & (US$ Million) Table 79. Eli Lilly and Company Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Glycopeptide Antibiotics Product Picture Figure 2. Global Glycopeptide Antibiotics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Glycopeptide Antibiotics Market Size 2017-2028 (US$ Million) Figure 4. United States Glycopeptide Antibiotics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Glycopeptide Antibiotics Market Size 2017-2028 (US$ Million) Figure 6. United States Glycopeptide Antibiotics Market Share in Global 2017-2028 Figure 7. Glycopeptide Antibiotics Report Years Considered Figure 8. Product Picture of Vancomycin Figure 9. Product Picture of Teicoplanin Figure 10. Product Picture of Bleomycin Figure 11. Global Glycopeptide Antibiotics Market Share by Type in 2022 & 2028 Figure 12. Global Glycopeptide Antibiotics Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Glycopeptide Antibiotics Market Share by Type (2017-2028) Figure 14. United States Glycopeptide Antibiotics Market Share by Type in 2022 & 2028 Figure 15. United States Glycopeptide Antibiotics Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Glycopeptide Antibiotics Market Share by Type (2017-2028) Figure 17. Product Picture of Enterococcus Treatment Figure 18. Product Picture of Staphylococcus Aureus Treatment Figure 19. Global Glycopeptide Antibiotics Market Share by Application in 2022 & 2028 Figure 20. Global Glycopeptide Antibiotics Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Glycopeptide Antibiotics Market Share by Application (2017-2028) Figure 22. United States Glycopeptide Antibiotics Market Share by Application in 2022 & 2028 Figure 23. United States Glycopeptide Antibiotics Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Glycopeptide Antibiotics Market Share by Application (2017-2028) Figure 25. North America Glycopeptide Antibiotics Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Glycopeptide Antibiotics Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Glycopeptide Antibiotics Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Glycopeptide Antibiotics Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Glycopeptide Antibiotics Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Glycopeptide Antibiotics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. ANI Pharmaceuticals Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 54. Hikma Pharmaceuticals plc Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 55. Aurobindo Pharma Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 56. Allergan Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 57. Theravance Biopharma Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 58. Shenwei Pharmaceutical Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 59. Zhejiang Hisun Pharmaceutical Co., Ltd. Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 60. Lytix Biopharma Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 61. Alvogen Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 62. Eli Lilly and Company Revenue Growth Rate in Glycopeptide Antibiotics Business (2017-2022) Figure 63. Bottom-up and Top-down Approaches for This Report Figure 64. Data Triangulation Figure 65. Key Executives Interviewed

ANI Pharmaceuticals Hikma Pharmaceuticals plc Aurobindo Pharma Allergan Theravance Biopharma Shenwei Pharmaceutical Zhejiang Hisun Pharmaceutical Co., Ltd. Lytix Biopharma Alvogen Eli Lilly and Company